Product category:
Contract research
News Release from: Molecular Profiles | Subject: Nanopass
Edited by the Laboratorytalk Editorial
Team on 23 January 2008
Nanoscale predictive analytical
screening for APIs
Molecular Profiles announces the latest addition to its nanoscale analytical services offering, Nanopass (nanoscale predictive analytical screening solution)
Nanopass is a comprehensive suite of complementary analytical techniques designed to optimise solid state selection of APIs and provide further insight into the formulation of APIs and excipients Processing of drug substance and excipients can have a significant effect on surface properties and subsequent stability/bioavailability of the active
This article was originally published on Laboratorytalk on 7 Oct 2003 at 8.00am (UK)
Related stories
Accelerating clinical trials
Senior pharma executives to gather at Geneva conference to explore latest strategies to speed up the clinical trials process
Combinatorial, organic and peptide chemistry
Publication of the 2003-2004 edition of popular Handbook of Combinatorial, Organic and Peptide Chemistry is announced, and copies are available free to researchers
To decide on the best formulation option, full understanding of bulk and surface physicochemical properties is required.
Enabling technologies allow empirical observations such as batch-to-batch variation, cohesive tendency and powder flow to be correlated to actual physicochemical properties.
The Nanopass suite has been equipped with an extended range of analytical techniques, including nanoscale determination of materials, mechanical and cohesive properties, chemical spectroscopy, physical properties (XRPD and thermal techniques), high-resolution spatial mapping and imaging of chemical, physical, thermal and material properties.
The unique solid state characterisation capabilities of the service platform enable users to compare bulk and surface properties of drug substance, excipients, granules and aggregates providing them with a detailed physicochemical profile.
The Nanopass service platform requires only small amounts of sample to provide precise and dependable material characterisation.
An example of the power of the analytical benefits afforded by Nanopass is the pre-formulation screening of the physical properties of single formulated particles using atomic force microscopy (AFM), which provides deep insight into the pharmaceutical function of developmental products.
"The introduction of this novel service platform further demonstrates our dedication to providing a high quality and reliable extension to the R+D capabilities within pharmaceutical companies," comments Nikin Patel, CEO, Molecular Profiles. Request a free brochure from Molecular Profiles ...
"Our team of specialised, experienced scientists will be building upon this platform to develop an extended range of service offerings intended to provide our customers with even more clarity and choice.".
• Molecular Profiles: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
